Abstract:After a large-scale radiological or nuclear event, hundreds of thousands of people may be exposed to ionizing radiation and require subsequent medical management. Acute exposure to moderate doses (2-6 Gy) of radiation can lead to the hematopoietic acute radiation syndrome, in which the bone marrow (BM) is severely compromised, and severe hemorrhage and infection are common. Previously, we have developed a panel of intracellular protein markers (FDXR, ACTN1, DDB2, BAX, p53 and TSPYL2), designed to reconstruct absorbed radiation dose from human peripheral blood (PB) leukocyte samples in humanized mice up to 3 days after exposure. The objective of this work was to continue to use the humanized mouse model to evaluate biomarker dose-/time- kinetics in human PB leukocytes in vivo, at an earlier (day 2) and later (day 7) time point, after exposure to total-body irradiation (TBI) doses of 0 to 2 Gy of X rays. In addition, to assess hematological sensitivity and radiation-induced injury, PB leukocyte cell counts, human BM hematopoietic stem cell (HSC) and progenitor cell [multipotent progenitor (MPP), common myeloid progenitor (CMP), granulocyte myeloid progenitor (GMP), megakaryocyte/erythrocyte progenitor (MEP) and multi-lymphoid progenitor (MLP)] levels were measured, and their correlation was also examined as the BM damages are difficult to assess by routine tests. Peripheral blood B-cells were significantly lower after TBI doses of 0.5 Gy on day 2 and 2 Gy on days 2 and 7; T-cells were significantly reduced only on day 2 after 2 Gy TBI. Bone marrow HSCs and MPP cells showed a dose-dependent depletion after irradiation with 0.5 Gy and 2 Gy on day 2, and after 1 Gy and 2 Gy on day 7. Circulating B cells correlated with HSCs, MPP and MLP cells on day 2, whereas T cells correlated with MPP, and myeloid cells correlated with MLP cells. On day 7, B cells correlated with MPP, CMP, GMP and MEP, while myeloid cells correlated with CMP, GMP and MEP. The intracellular leukocyte biomarkers were able to discriminate unirradiated and irradiated samples at different time points calculated by receiver operating characteristic (ROC) curve. Using machine learning algorithm methods, combining ACTN1, p53, TSPYL2 and PB-T cell and PB-B cell counts served as a strong predictor (area under the ROC >0.8) to distinguish unirradiated and irradiated samples independent of the days after TBI. The results further validated our biomarker-based triage assay and additionally evaluated the radiation sensitivity of the hematopoietic system after TBI exposures.

Identification Of The Differentially Expressed Protein Biomarkers In Rat Blood Plasma In Response To Gamma Irradiation

Discovering the Radiation Biomarkers in the Plasma of Total-Body Irradiated Leukemia Patients

Screening Of Lipids For Early Triage And Dose Estimation After Acute Radiation Exposure In Rat Plasma Based On Targeted Lipidomics Analysis

Developing point of care and high-throughput biological assays for determining absorbed radiation dose

Serum Proteins As New Biomarkers for Whole-Body Exposure to High- and Low-LET Ionizing Radiation

Targeted lipidomics-based study of radiation-induced metabolite profiles changes in plasma of total body irradiation cases

Biomarkers for Radiation Biodosimetry and Correlation with Hematopoietic Injury in a Humanized Mouse Model

Biofluid Metabolomics and Lipidomics of Mice Exposed to External Very High-Dose Rate Radiation

Changes in the Adhesion and Migration Ability of Peripheral Blood Cells: Potential Biomarkers Indicating Exposure Dose.

Proteomic analysis of plasma at the preterminal stage of rhesus nonhuman primates exposed to a lethal total-body dose of gamma-radiation

Identification of the Kupffer cell-derived circulating IGFBP-3 as a universal radiation biomarker for heavy ion, proton, and X-ray exposure

Transcriptional investigation of biomarkers for late radiation-induced lung toxicity in mice

Experimental Studies on Radiation-induced Expression Changes of Genes Related to Cell Cycle Control and DNA Damage Response

Long-term transcriptomic and proteomic effects in Sprague Dawley rat thyroid and plasma after internal low dose 131I exposure

Radiation metabolomics. 1. Identification of minimally invasive urine biomarkers for gamma-radiation exposure in mice

BAX and DDB2 as biomarkers for acute radiation exposure in the human blood ex vivo and non-human primate models

Biomarker dosimetry of acute low level of thermal neutrons and radiation adaptive response effect on rats

Radiation Signature in Plasma Metabolome of Total-Body Irradiated Nonhuman Primates and Clinical Patients

Candidate biomarkers and persistent transcriptional responses after low and high dose ionizing radiation at high dose rate

Changes in patient peripheral blood cell microRNAs after total body irradiation during hematopoietic stem cell transplantation

Gene Expression Profiles from Heart, Lung and Liver Samples of Total-Body-Irradiated Minipigs: Implications for Predicting Radiation-Induced Tissue Toxicity